Mass balance, metabolism, and pharmacokinetics of [(14)C]amdizalisib, a clinical-stage novel oral selective PI3Kδ inhibitor for the treatment of non-hodgkin's lymphoma, in healthy Chinese volunteers
在健康中国志愿者中,[(14)C]amdizalisib(一种用于治疗非霍奇金淋巴瘤的临床阶段新型口服选择性PI3Kδ抑制剂)的质量平衡、代谢和药代动力学研究
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1478234
Zhao, Chun-Yang; Zhang, Li-Jun; Sun, Chan; Yu, Cheng-Yin; Wang, Jian; Sai, Yang; Su, Wei-Guo; Chen, Qian; Wang, Wei; Jia, Jing-Ying; Liu, Gang-Yi; Liu, Yan-Mei